cysteamine isobionic-amide complex

Cysteamine isobionic-amide complex is a topical dermatological formulation combining cysteamine (a naturally occurring antioxidant with skin depigmenting properties) and isobionicamide (a pyridine-family molecule with depigmenting and anti-inflammatory effects) designed to treat hyperpigmentation disorders, particularly **melasma**[1][4][8]. This complex shows synergistic action—cysteamine inhibits melanin synthesis via antioxidant and chelation mechanisms, while isobionicamide inhibits melanosomal transfer and reduces inflammation, improving tolerability and depigmentation efficacy compared to cysteamine alone[2][7]. Clinical studies demonstrate equivalent efficacy and rapid onset of action compared to modified Kligman’s formula (the reference standard for melasma), with improved patient satisfaction and quality of life[1][6][8][10]. The product is marketed as "Cyspera" and developed by Scientis, primarily indicated for melasma and potentially useful for photoaging and other hyperpigmentation disorders[7][11].

Brand names

Cyspera

Other names

cysteamine-isobionicamide complexisobionicamide-cysteamine complex